Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5,908.00 JPY | +1.44% |
|
+0.82% | +22.19% |
| Market Cap | 9,434B 60.63B 52.17B 48.96B 44.79B 83.6B 5,732B 84.26B 579B 226B 2,929B 228B 223B | P/E 2027 * |
46.8x | P/E 2028 * | 29.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13,340B 85.74B 73.77B 69.23B 63.34B 118B 8,105B 119B 819B 319B 4,142B 322B 315B | EV / Sales 2027 * |
2.84x | EV / Sales 2028 * | 2.75x |
| Free-Float |
99.26% | Yield 2027 * |
3.46% | Yield 2028 * | 3.53% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
OTC Markets
| TKPHF | Delayed | |
|
Boerse Muenchen
| TKD | Real-time | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript : Takeda Pharmaceutical Company Limited
| 1 day | +1.44% | ||
| 1 week | +0.82% | ||
| Current month | +2.48% | ||
| 1 month | +7.16% | ||
| 3 months | +21.81% | ||
| 6 months | +1.97% | ||
| Current year | +22.19% |
| 1 week | 5,721 |  | 5,917 |
| 1 month | 5,225 | | 5,917 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/2024 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% | ||
| 18/08/26 | Sell | Head of Human Resources | -12,980 | 0.0008% | ||
| 11/08/26 | Sell | Pres., Global Supply & Quality | -20,363 | 0.0013% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.44% | +0.82% | +30.85% | +31.00% | 58.62B | |
| -0.22% | -1.87% | +56.42% | +106.76% | 1,034B | |
| +0.95% | +4.64% | +56.24% | +73.08% | 663B | |
| -0.46% | +0.96% | +23.02% | +78.39% | 462B | |
| +2.09% | -2.06% | +32.28% | +38.37% | 344B | |
| 0.00% | +5.36% | +27.40% | +47.50% | 307B | |
| +1.42% | +0.26% | -0.52% | +13.62% | 251B | |
| +0.08% | +1.54% | +56.32% | +74.68% | 239B | |
| -0.03% | +2.13% | -17.30% | -53.99% | 207B | |
| +0.20% | +0.99% | +33.05% | +100.01% | 186B | |
| Average | +0.70% | -0.69% | +29.78% | +50.94% | 375.2B | |
| Weighted average by Cap. | +0.52% | -0.84% | +38.25% | +67.54% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,701B 30.21B 26B 24.4B 22.32B 41.66B 2,856B 41.99B 289B 112B 1,460B 113B 111B | 4,780B 30.72B 26.43B 24.81B 22.7B 42.36B 2,904B 42.7B 293B 114B 1,484B 115B 113B |
| Net income | 197B 1.26B 1.09B 1.02B 933M 1.74B 119B 1.76B 12.07B 4.7B 61.02B 4.74B 4.64B | 322B 2.07B 1.78B 1.67B 1.53B 2.86B 196B 2.88B 19.79B 7.71B 100B 7.78B 7.61B |
| Net Debt | 3,907B 25.11B 21.6B 20.27B 18.55B 34.62B 2,374B 34.89B 240B 93.4B 1,213B 94.29B 92.23B | 3,703B 23.8B 20.48B 19.22B 17.58B 32.82B 2,250B 33.08B 227B 88.54B 1,150B 89.38B 87.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | JP¥5,908.00 | +1.44% | 3,253,000 |
| 02/09/26 | JP¥5,824.00 | -0.36% | 3,692,600 |
| 01/09/26 | JP¥5,845.00 | +1.39% | 3,502,800 |
| 31/08/26 | JP¥5,765.00 | -0.60% | 6,623,900 |
| 28/08/26 | JP¥5,800.00 | -0.15% | 3,017,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
